Segui
Péter Fülöp
Péter Fülöp
Associate professor, Dept. of Internal Medicine, University of Debrecen
Email verificata su belklinika.com
Titolo
Citata da
Citata da
Anno
Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice
M Horimoto, P Fülöp, Z Derdák, JR Wands, G Baffy
Hepatology 39 (2), 386-392, 2004
1482004
Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-κB activation and oxidative stress
Z Derdák, P Fülöp, E Sabo, R Tavares, EP Berthiaume, MB Resnick, ...
Carcinogenesis 27 (5), 956-961, 2006
922006
Association of chemerin with oxidative stress, inflammation and classical adipokines in non‐diabetic obese patients
P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh
Journal of cellular and molecular medicine 18 (7), 1313-1320, 2014
912014
Lack of UCP2 reduces fas‐mediated liver injury in ob/ob mice and reveals importance of cell‐specific UCP2 expression
P Fülöp, Z Derdák, A Sheets, E Sabo, EP Berthiaume, MB Resnick, ...
Hepatology 44 (3), 592-601, 2006
752006
High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
K Gaál, T Tarr, H Lőrincz, V Borbás, I Seres, M Harangi, P Fülöp, ...
Lipids in health and disease 15, 1-8, 2016
662016
Orlistat increases serum paraoxonase activity in obese patients
M Audikovszky, G Pados, I Seres, M Harangi, P Fülöp, E Katona, L Illyés, ...
Nutrition, metabolism and cardiovascular diseases 17 (4), 268-273, 2007
512007
HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats.
G Paragh, P Kertai, P Kovacs, G Paragh Jr, P Fülöp, G Foris
Anticancer research 23 (5A), 3949-3954, 2003
512003
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects
H Lőrincz, M Katkó, M Harangi, S Somodi, K Gaál, P Fülöp, G Paragh, ...
Clinical endocrinology 81 (3), 370-377, 2014
502014
Dynamic interplay between metabolic syndrome and immunity
G Paragh, I Seres, M Harangi, P Fülöp
Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular …, 2014
502014
Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis
P Fülöp, M Harangi, I Seres, G Paragh
Chemico-biological interactions 259, 388-393, 2016
402016
Plasminogen Activator Inhibitor‐1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
S Somodi, I Seres, H Lőrincz, M Harangi, P Fülöp, G Paragh
International Journal of Endocrinology 2018 (1), 9596054, 2018
372018
Different anticancer effects of fluvastatin on primary hepatocellular tumors and metastases in rats
G Paragh, G Fóris, G Paragh Jr, I Seres, Z Karányi, P Fülöp, Z Balogh, ...
Cancer letters 222 (1), 17-22, 2005
362005
Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary
G Paragh, M Harangi, Z Karányi, B Daróczy, Á Németh, P Fülöp
Atherosclerosis 277, 262-266, 2018
282018
The effect of low-intensity aerobic training on cognitive functions of severely deconditioned subacute and chronic stroke patients: a randomized, controlled pilot study
A Debreceni-Nagy, J Horváth, NB Kovács, P Fülöp, Z Jenei
International Journal of Rehabilitation Research 42 (3), 275-279, 2019
262019
Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
G Paragh, Á Németh, M Harangi, M Banach, P Fülöp
Lipids in health and disease 21 (1), 21, 2022
252022
Effects of simvastatin on serum paraoxonase activity
Z Balogh, P Fülöp, I Seres, M Harangi, E Katona, P Kovacs, B Kosztáczky, ...
Clinical Drug Investigation 21, 505-510, 2001
232001
Assessment of associations between serum lipoprotein (a) levels and atherosclerotic vascular diseases in hungarian patients with familial hypercholesterolemia using data mining …
Á Németh, B Daróczy, L Juhász, P Fülöp, M Harangi, G Paragh
Frontiers in Genetics 13, 849197, 2022
192022
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications
N Zsíros, P Koncsos, H Lőrincz, I Seres, M Katkó, A Szentpéteri, VE Varga, ...
Clinical biochemistry 49 (12), 862-867, 2016
192016
Increased hair selenium concentration in hyperlipidemic patients
P Fülöp, I Seres, Z Jenei, I Juhász, G Paragh
Journal of Cellular and Molecular Medicine 17 (3), 350-355, 2013
182013
The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome
I Seres, G Foris, Z Varga, B Kosztaczky, A Kassai, Z Balogh, P Fülöp, ...
The Journal of membrane biology 214, 91-98, 2006
182006
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20